1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival outcomes of screening with breast MRI in high-risk women
    Meeting Abstract

    Bae, M. S.; Sung, J. S.; Han, W.; Bernard-Davila, B.; Bara, F. R.; Sutton, E. J.; Comstock, C.; Jochelson, M. S.; Morris, E. A.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
    Meeting Abstract

    Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Phase 3 prognostic analysis of the automated bone scan index (aBSI) in men with bone-metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Armstrong, A. J.; Edenbrandt, L.; Bondesson, E.; Anand, A.; Nordle, O.; Carducci, M. A.; Morris, M. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Initial efficacy of anti-lymphocyte activation gene-3 (anti-LAG-3; BMS-986016) in combination with nivolumab (nivo) in pts with melanoma (MEL) previously treated with anti-PD-1/PD-L1 therapy
    Meeting Abstract

    Ascierto, P. A.; Melero, I.; Bhatia, S.; Bono, P.; Sanborn, R. E.; Lipson, E. J.; Callahan, M. K.; Gajewski, T.; Gomez-Roca, C. A.; Hodi, F. S.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Inequities in cancer outcomes between different healthcare systems in Brazil
    Meeting Abstract

    Ashing, K. T.; Bergerot, C. D.; Philip, E. J.; Okuma, G.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Genomic comparison of matched primary and metastatic germ cell tumors (GCT)
    Meeting Abstract

    Audenet, F.; Donoghue, M.; Pietzak, E. J.; Isharwal, S.; Cheng, M. L.; Iyer, G.; Funt, S.; Bajorin, D. F.; Al-Ahmadie, H.; Reuter, V. E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Do pancreas cancer stem cells play crucial role in survival outcome?
    Meeting Abstract

    Askan, G.; Sahin, I. H.; Capanu, M.; Turkekul, M.; Yu, K. H.; Lowery, M. A.; Basturk, O.; Iacobuzio-Donahue, C.; O'Reilly, E. M.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Translating prostate cancer working group (PCWG) criteria into a quantitative progression biomarker in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Anand, A.; Heller, G.; Scher, H. I.; Morris, M. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Ironclad: A randomized phase III study of ibrutinib (Ibr) or no consolidation following autologous hematopoietic stem cell transplantation (AutoHCT) for relapsed/refractory activated-B-cell (ABC) subtype diffuse large B-cell lymphoma (DLBCL)
    Meeting Abstract

    Andreadis, C.; Fenske, T. S.; Hill, B. T.; Stiff, P. J.; Grinblatt, D. L.; Hsi, E. D.; Kelley, T.; Richards, K. L.; Kostakoglu, L.; Schoder, H.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Safety and clinical activity of first-line durvalumab in advanced NSCLC: Updated results from a Phase 1/2 study
    Meeting Abstract

    Antonia, S. J.; Brahmer, J. R.; Balmanoukian, A. S.; Kim, D. W.; Kim, S. W.; Ahn, M. J.; Jamal, R.; Jaeger, D.; Ott, P. A.; Ascierto, P. A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save